MondayDec 16, 2024 1:34 pm

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Eyes Clear Path Forward for Buntanetap

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company concluded the third quarter with the completion of significant milestones and a clear path forward for its lead candidate, buntanetap. “Buntanetap is an innovative drug designed to target neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein and TDP43,” reads a recent article. “This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying, positioning buntanetap as a potential breakthrough in treating neurodegenerative diseases.”…

Continue Reading

MondayDec 16, 2024 11:05 am

QualityStocksNewsBreaks – CannExpo 2025 to Showcase Innovative Products, Trends in Celebration of All Things Cannabis

CannExpo 2025, Toronto's Cannabis Lifestyle Show, is set to blaze into the Queen Elizabeth Building at Exhibition Place on March 21-22, 2025. The event will bring together enthusiasts, curious newcomers and professionals from the cannabis industry. An eclectic mix of exhibitors will be featured, from cutting-edge growers and innovative product developers to trendsetting accessory makers and wellness experts. The one-stop-shop for discovering the latest and greatest in the world of cannabis will be buzzing with engaging panels and discussions on hot topics. To view the full press release, visit https://ibn.fm/rv12p About CannExpo 2025 CannExpo 2025 is more than just an…

Continue Reading

MondayDec 16, 2024 9:10 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Secures FDA Clearance for Innovative Arrhythmia Assessment Device

HeartBeam (NASDAQ: BEAT) has received FDA 510(k) clearance for its groundbreaking HeartBeam system, a credit card-sized, cable-free ECG device designed for comprehensive arrhythmia assessment. The system enables patients to record high-fidelity heart signals from three directions during symptoms, with data transmitted to physicians for timely review and action. This milestone marks the first FDA-cleared device of its kind and lays the foundation for future advancements, including synthesized 12-lead ECGs, AI-driven arrhythmia detection, and heart attack risk assessment. HeartBeam aims to transform cardiac care by delivering actionable insights and predictive diagnostics for patients and physicians globally. To view the full press…

Continue Reading

MondayDec 16, 2024 8:00 am

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Advances Exploration at Storm and Epworth Projects in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) provided updates on its 2024 exploration activities at the Storm Copper and Epworth Projects in Nunavut. At Storm, 22,475 meters of drilling confirmed consistent copper grades and identified new targets, with a maiden resource and development study expected in early 2025. At Epworth, Aston Bay expanded its claims by 11,900 hectares, conducted extensive geophysical surveys, and plans to release a comprehensive analysis of the results in January. Additional drilling at Storm refined the geological model, with new discoveries at the Squall Prospect highlighting promising mineralization, including assays of 2.4% copper and 5 g/t silver.…

Continue Reading

FridayDec 13, 2024 11:45 am

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL): A Leader in Technology and Innovation

Alphabet (NASDAQ: GOOGL, GOOG) is a global leader in technology, primarily known for its search engine, Google. The company has expanded its reach into various sectors, including artificial intelligence (“AI”), cloud computing and digital advertising. With competitors like Microsoft and Amazon, Alphabet continues to innovate and maintain its competitive edge. Alphabet’s recent launch of Gemini 2.0, its latest AI model, underscores its commitment to leading the AI sector. This initiative is part of a broader strategy to introduce innovative applications, reinforcing its role in the computing industry. As highlighted by Goldman Sachs, Alphabet is “well positioned for the long term”…

Continue Reading

FridayDec 13, 2024 8:00 am

QualityStocksNewsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) (NEO: SUNN) (FSE: GY2) Releases Results of Annual General and Special Meeting

SolarBank (NASDAQ: SUUN) (CSE: SUNN) (NEO: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., has announced the results of its 2024 annual general and special meeting of shareholders. The nominees listed in the management information circular for the meeting were elected as directors of SolarBank. The announcement includes detailed results of the election of directors as well as other items voted for in the meeting. To view the full press release, visit https://ibn.fm/V1JCp About SolarBank Corporation SolarBank Corporation is an independent renewable and…

Continue Reading

ThursdayDec 12, 2024 2:58 pm

QualityStocksNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned to Capitalize on the Rise of AI

McEwen Mining (NYSE: MUX) (TSX: MUX) is poised to benefit amid the growing use of artificial intelligence (“AI”) in everyday life activities. As the use of AI tools trends upward, such as in the job application process among countless others, “The companies behind those AI tools could be basking in the limelight of their innovations, but behind this revolution lies several unsung heroes; including metals like gold and copper making it possible for AI components like chips and data centers to be built,” reads a recent article. “Companies such as McEwen Mining, leveraging their expertise to help address the surging demand for…

Continue Reading

ThursdayDec 12, 2024 1:35 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) at the Forefront of Cancer Treatment Innovation

Calidi Biotherapeutics (NYSE American: CLDI) was featured in a recent article that showcased the company as a compelling example of progress of emerging therapies and advances that are reshaping the fight against cancer. Calidi’s “recent data on its RTNova(TM) systemic enveloped virotherapy technology demonstrates the potential of cutting-edge solutions to revolutionize cancer care,” the article reads. “At two major conferences—the International Oncolytic Virotherapy Conference (‘IOVC’) and the Society for Immunotherapy of Cancer (‘SITC’) Annual Meeting—Calidi presented groundbreaking data supporting the capabilities of its proprietary RTNova systemic enveloped virotherapy platform. RTNova is designed to address the limitations of traditional virotherapy by offering…

Continue Reading

ThursdayDec 12, 2024 12:25 pm

QualityStocksNewsBreaks – Skyview Innovations Poised at Forefront of Spatial Computing, Immersive Tech with Hovercraft Acquisition

Skyview Innovations today announced its acquisition of Hovercraft, marking an important next step towards creating a new global network of creative and innovation-led companies. Skyview’s recent acquisition of U.K.-based agency OMM complements this transaction, forming an industry-leading global network in experiential, spatial computing and emergent technologies. Bringing these companies together exemplifies Skyview’s commitment to driving innovation and enhancing user experiences across various platforms in physical and virtual environments. “This strategic acquisition positions Skyview Innovations at the forefront of the spatial computing and immersive technology sector, further solidifying its role as a global industry leader,” said Skyview CEO Jeff Kaplan. To…

Continue Reading

ThursdayDec 12, 2024 8:00 am

QualityStocksNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) Gains National Recognition with PyroDelta’s Innovative Thermoelectric Technology

First Tellurium (CSE: FTEL) (OTCQB: FSTTF) announced that its subsidiary, PyroDelta Energy, and its tellurium-based thermoelectric generator were featured in a USA Today article titled "How PyroDelta’s Thermoelectric Technology Could Change Energy Independence." The piece highlights the generator's ability to produce power without reliance on large batteries, solar panels, or the electrical grid. PyroDelta’s Director of Engineering, Michael Abdelmaseh, emphasized the device's scalability, versatility, and potential to address critical energy storage challenges. He also noted the generator's automotive application, which converts waste heat from engine coolant into electricity, replacing the alternator entirely. First Tellurium President and CEO Tyrone Docherty expressed optimism…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered